arabinofuranosyluracil and Colorectal Neoplasms

arabinofuranosyluracil has been researched along with Colorectal Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akhurst, T; Balatoni, J; Banerjee, D; Bertino, JR; Blasberg, R; Doubrovin, M; Finn, R; Fong, Y; Gade, T; Gusani, NJ; Koutcher, JA; Larson, S; Mayer-Kuckuk, P; Tjuvajev, JG1
Alauddin, MM; Bading, JR; Bathija, P; Conti, PS; Fissekis, JD; Koda, RT; Koszalka, GW; Shahinian, AH; Vail, A1
Anderson, LW; Brown-Proctor, C; Collins, JM; Egorin, MJ; Eiseman, JL; Hamburger, DR; Joseph, E; Kinahan, PE; Klecker, RW; Mathis, CA; Pan, SS1
Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H1

Trials

1 trial(s) available for arabinofuranosyluracil and Colorectal Neoplasms

ArticleYear
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:3

    Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution

2006

Other Studies

3 other study(ies) available for arabinofuranosyluracil and Colorectal Neoplasms

ArticleYear
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:9

    Topics: Animals; Animals, Genetically Modified; Arabinofuranosyluracil; Cell Line, Tumor; Colorectal Neoplasms; Feasibility Studies; Folic Acid Antagonists; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Nude; Recombinant Fusion Proteins; Tetrahydrofolate Dehydrogenase; Thymidine Kinase; Tissue Distribution; Transplantation, Heterologous; Viral Proteins; Whole-Body Counting

2003
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
    Nuclear medicine and biology, 2004, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line, Tumor; Colorectal Neoplasms; DNA, Neoplasm; Female; Male; Metabolic Clearance Rate; Organ Specificity; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thymidine; Tissue Distribution

2004
Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Oct-01, Volume: 10, Issue:19

    Topics: Animals; Arabinofuranosyluracil; Colorectal Neoplasms; DNA, Neoplasm; Female; Fluorouracil; HT29 Cells; Humans; Mice; Mice, SCID; Positron-Emission Tomography; Thymidylate Synthase; Time Factors; Tissue Distribution; Tritium; Xenograft Model Antitumor Assays

2004